|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of MorphoSys (NASDAQ: MOR) through any online brokerage.
The latest price target for MorphoSys (NASDAQ: MOR) was reported by Morgan Stanley on January 14, 2022. The analyst firm set a price target for 0.00 expecting MOR to fall to within 12 months (a possible -100.00% downside). 7 analyst firms have reported ratings in the last year.
The stock price for MorphoSys (NASDAQ: MOR) is $7.57 last updated Fri Jan 28 2022 21:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for MorphoSys.
MorphoSys’s $Q4 earnings are confirmed for after-market on March 14, 2022.
There is no upcoming split for MorphoSys.
MorphoSys is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.